Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre
Strasbourg, France
NCT Number: NCT00213837
This trial will study the reconstruction of the anterior part of the mandible and the adjacent soft tissue parts by a mandibular prosthesis made in porous titanium, associated or not, to a latissimus dorsi or pectoral flap, to avoid reconstruction with free microanastomosed bone flaps that are often associated with important morbidity.
The implant is consolidated by two prolonged parallel plates of titanium, allowing their fixation to the bone, easy to fix in a short time.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Strasbourg, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Replacement of mandibular bone after partial or total mandible resection,avoiding then bone grafting. The porous titanium prosthesis is implanted under general anaesthesia in laryngeal surgeries. Bone resection and prosthesis placement is performed during the same surgical intervention. The prosthesis is attached onto the healthy bone with surgical screws. Simultaneous grafting of vascularised tissues may be done if the prosthesis surrounding area has been strongly irradiated.
Time frame: 3 months after surgery
Time frame: 8, 15, 30 days and 3 months after surgery
Time frame: 8, 15, 30 days, 3, 6 months after surgery and then every 6 months during the whole trial
University Hospital, Strasbourg, France
Other
Reconstruction Implant Bone (Anterior Mandibular Arch) After Removing Using Porous Titanium Prosthesis in ENT Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04725305
Hemorrhage, Neurologic Manifestations
Houston, Texas, United States
View Trial DetailsNCT03931226
Dermatologic Disease, Otorhinolaryngologic Diseases
Toulouse, France
View Trial DetailsNCT02811549
Asymmetrical Hearing Loss, Ear Diseases
Sarasota, Florida, United States
View Trial DetailsNCT05467059
Apnea, Dyssomnias
Paris, France
View Trial Details